MeThreeSixty adds GLP-1 dose tracking and AI future-self video tool

MeThreeSixty is rolling out two new features for users tracking weight-loss journeys: GLP-1 Dose Tracking and FutureMe Moment. The update combines medication logs, body scans and body composition data in one app, while adding an AI-generated video aimed at helping users visualize progress.

Why it matters: - GLP-1 users can now track medication, body composition and scan history in one place instead of using separate tools. - The new features are designed to help people monitor lean mass, not just weight, during treatment. - MeThreeSixty is also leaning into motivation tools that frame progress around long-term health goals.

What happened: - MeThreeSixty, the mobile 3D body scanning app developed by Size Stream, introduced GLP-1 Dose Tracking and FutureMe Moment on October 14, 2026. - GLP-1 Dose Tracking lets users record medication names, doses, personal notes and injection sites. - FutureMe Moment creates an AI-generated video based on a user headshot, target weight and 3D scan data. - Both features are free and available now on iOS and Android.

The details: - The app already supports weight, body composition, body measurements and 3D body scans in one interface. - MeThreeSixty has supported more than 3 million scans from more than 1 million members. - GLP-1 Dose Tracking is available in English and Spanish in every country where MeThreeSixty is offered. - Users tracking weight loss can continue logging weight, body composition metrics and 3D body scans alongside medication history. - FutureMe Moment builds on FutureMe, an existing feature that lets users add or reduce weight on a current 3D model to visualize a goal body. - Each new scan shows how a user’s body is changing over time. - The app uses smartphone camera scanning technology that typically takes less than a minute. - The platform provides 21 body measurements and body composition metrics including body fat percentage and lean mass. - In a peer-reviewed study published in the 3DBODY.TECH Journal in December 2025, Size Stream researchers reported that mobile body fat mass estimates closely matched DXA scans, with an R² value above 0.96. - Body scans are processed using anonymous silhouettes, and the full-body photos taken during a scan are not uploaded or stored in the cloud. - MeThreeSixty can be found at more information.

Between the lines: - The feature launch suggests MeThreeSixty is positioning itself as a single hub for people using GLP-1 medications and tracking broader health changes. - The focus on lean mass reflects a common concern in weight-loss treatment, where users may want more than scale-based feedback. - The AI video feature adds a more emotional, aspirational layer to a data-heavy tracking app. - Size Stream is tying consumer features to scanning technology it says is used by leading pharmaceutical firms in clinical trials.

What's next: - MeThreeSixty will likely use GLP-1 tracking and FutureMe Moment to deepen engagement with users managing long-term health goals. - The company’s next test is whether users adopt the new tools as part of a daily routine, not just as a novelty. - Ongoing scan data will continue showing body changes over time as users update their profiles.